Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Pulmonary Hypertension

  Free Subscription


1 Am J Respir Cell Mol Biol
4 Am J Respir Crit Care Med
1 bioRxiv
1 BMC Pulm Med
1 Clin Nucl Med
1 Comb Chem High Throughput Screen
1 Compr Physiol
2 Curr Probl Cardiol
2 Eur Heart J
1 Eur J Cardiothorac Surg
1 Eur J Heart Fail
1 Eur J Intern Med
2 Eur J Pharmacol
1 Indian J Pediatr
4 J Am Heart Assoc
1 J Card Fail
1 J Cardiopulm Rehabil Prev
1 J Pharmacol Sci
1 J Physiol
3 JACC Asia
1 Life Sci
1 Nat Med
1 Pediatr Cardiol
1 Pediatr Int
1 Pulm Circ
2 Retina
1 Rev Esp Cardiol (Engl Ed)
1 Rev Mal Respir
1 Sci Rep
1 Yonsei Med J
1 Zhonghua Er Ke Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Respir Cell Mol Biol

  1. ALOTAIBI M, Fernandes T, Tang AB, Magalang GA, et al
    Sex-related Differences in Eicosanoid Levels in Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2023;68:228-231.

    Am J Respir Crit Care Med

    Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: For Real?
    Am J Respir Crit Care Med. 2023;207:238-240.

    Comparing the Incomparable: Identifying Common Themes Across a Diverse Landscape to Address Equity in Lung Allocation.
    Am J Respir Crit Care Med. 2023;207:236-238.

  4. HASSAN HJ, Naranjo M, Ayoub N, Housten T, et al
    Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry.
    Am J Respir Crit Care Med. 2023;207:312-322.
    PubMed         Abstract available

  5. KOLAITIS NA, Chen H, Calabrese DR, Kumar K, et al
    The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision.
    Am J Respir Crit Care Med. 2023;207:300-311.
    PubMed         Abstract available


  6. AKIL A, Ziegeler S, Rehers S, Lavae-Mokhtari M, et al
    Lung Volume Reduction Surgery Reduces Pulmonary Arterial Hypertension Associated With Severe Lung Emphysema and Hypercapnia.
    ASAIO J. 2023;69:218-224.
    PubMed         Abstract available

  7. ANEGAWA E, Seguchi O, Mochizuki H, Kuroda K, et al
    Pulmonary Vascular Reverse Remodeling After Left Ventricular Assist Device Implantation in Patients With Pulmonary Hypertension.
    ASAIO J. 2023;69:151-158.
    PubMed         Abstract available


  8. VOGEL NT, Annis J, Prisco SZ, Kazmirczak F, et al
    Ferroptosis Promotes Pulmonary Hypertension.
    bioRxiv. 2023 Jan 20:2023.01.19.524721. doi: 10.1101/2023.01.19.524721.
    PubMed         Abstract available

    BMC Pulm Med

  9. HOU C, Xie L, Wang T, Zheng J, et al
    Comparative transcription profiling of mRNA and lncRNA in pulmonary arterial hypertension after C75 treatment.
    BMC Pulm Med. 2023;23:46.
    PubMed         Abstract available

    Clin Nucl Med

  10. DIXON JT, DiFilippo FP, Renapurkar RD, Huang SS, et al
    Novel Depiction of Collateral Flow in Chronic Thromboembolic Pulmonary Hypertension Using 4D Dynamic 82Rb PET/CT.
    Clin Nucl Med. 2023 Jan 20. doi: 10.1097/RLU.0000000000004567.
    PubMed         Abstract available

    Comb Chem High Throughput Screen

  11. LI C, Xia J, Yiminniyaze R, Dong L, et al
    Hub Genes and Immune Cell Infiltration in Hypoxia-Induced Pulmonary Hypertension: Bioinformatics Analysis and In Vivo Validation.
    Comb Chem High Throughput Screen. 2023.
    PubMed         Abstract available

    Compr Physiol

  12. GU S, Goel K, Forbes LM, Kheyfets VO, et al
    Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.
    Compr Physiol. 2023;13:4295-4319.
    PubMed         Abstract available

    Curr Probl Cardiol

  13. ABBASI MA, Albulushi A, Dhar K, Lowes B, et al
    The Effect of Exercise on Endothelin 1 Level in Patients With Pulmonary Hypertension.
    Curr Probl Cardiol. 2023 Jan 28:101627. doi: 10.1016/j.cpcardiol.2023.101627.

  14. ISSA R, Minhas AMK, Issa R, Ariss RW, et al
    Urban-Rural disparities in pulmonary hypertension-related mortality between 2004 and 2019: a call to improve access to specialty care centers for rural residents in the United States.
    Curr Probl Cardiol. 2023 Jan 30:101623. doi: 10.1016/j.cpcardiol.2023.101623.
    PubMed         Abstract available

    Eur Heart J

  15. ROSENKRANZ S, Delcroix M, Giannakoulas G, Hoeper MM, et al
    The 'Ten Commandments' of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
    Eur Heart J. 2023 Feb 1:ehad018. doi: 10.1093.

  16. MA Q, Yang Q, Xu J, Sellers HG, et al
    Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models.
    Eur Heart J. 2023 Jan 31:ehad044. doi: 10.1093.
    PubMed         Abstract available

    Eur J Cardiothorac Surg

  17. KAYAWAKE H, Tanaka S, Yamada Y, Baba S, et al
    Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension.
    Eur J Cardiothorac Surg. 2023 Feb 1:ezad024. doi: 10.1093.
    PubMed         Abstract available

    Eur J Heart Fail

    The beta3-adrenoreceptor agonist mirabegron for the treatment of combined pre- and post-capillary pulmonary hypertension: new pathway or dead end?
    Eur J Heart Fail. 2023 Jan 24. doi: 10.1002/ejhf.2780.

    Eur J Intern Med

  19. LEVI M
    Identifying patients at risk for chronic thromboembolic pulmonary hypertension.
    Eur J Intern Med. 2023 Jan 25:S0953-6205(23)00025.

    Eur J Pharmacol

  20. ABDULKAREEM AO, Tiwari P, Lone ZR, Iqbal H, et al
    Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension.
    Eur J Pharmacol. 2023 Jan 30:175558. doi: 10.1016/j.ejphar.2023.175558.
    PubMed         Abstract available

  21. JIANG Y, Huang J, Xia Y, Sun Z, et al
    Hypoxia activates GPR146 which participates in pulmonary vascular remodeling by promoting pyroptosis of pulmonary artery endothelial cells.
    Eur J Pharmacol. 2023;941:175502.
    PubMed         Abstract available

    Indian J Pediatr

  22. SAHIN C, Pamukcu O
    Serum Cystatin C: A Potential Biomarker in Pulmonary Hypertension in Children.
    Indian J Pediatr. 2023 Feb 2. doi: 10.1007/s12098-023-04487.

    J Am Heart Assoc

  23. ALLEN BJ, Frye H, Ramanathan R, Caggiano LR, et al
    Biomechanical and Mechanobiological Drivers of the Transition From PostCapillary Pulmonary Hypertension to Combined Pre-/PostCapillary Pulmonary Hypertension.
    J Am Heart Assoc. 2023 Feb 3:e028121. doi: 10.1161/JAHA.122.028121.
    PubMed         Abstract available

  24. FUJII H, Taniguchi Y, Yoneda S, Miwa K, et al
    Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease.
    J Am Heart Assoc. 2023 Feb 3:e026466. doi: 10.1161/JAHA.122.026466.
    PubMed         Abstract available

  25. DAIGO K, Katsumata Y, Esaki K, Iwasawa Y, et al
    Predictors of Improvement in Exercise Tolerance After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    J Am Heart Assoc. 2023 Jan 31:e027395. doi: 10.1161/JAHA.122.027395.
    PubMed         Abstract available

  26. CHENG R, Conrad M
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Patients With Chronic Obstructive Pulmonary Disease: A Note of Caution.
    J Am Heart Assoc. 2023 Feb 3:e028898. doi: 10.1161/JAHA.122.028898.

    J Card Fail

  27. ARAS MA, Abreau S, Mills H, Radhakrishnan L, et al
    Electrocardiogram Detection of Pulmonary Hypertension Using Deep Learning.
    J Card Fail. 2023 Jan 24:S1071-9164(23)00012.
    PubMed         Abstract available

    J Cardiopulm Rehabil Prev

  28. SYKES AV, Sonners C, Schmickl CN, Raphelson J, et al
    The Impact of Underlying Obstructive Sleep Apnea Treatment on Exercise Capacity in Patients With Pulmonary Hypertension Undergoing a Cardiac Rehabilitation Program.
    J Cardiopulm Rehabil Prev. 2022 Dec 14. doi: 10.1097/HCR.0000000000000745.
    PubMed         Abstract available

    J Pharmacol Sci

  29. KAWADE A, Yamamura A, Kondo R, Suzuki Y, et al
    Corosolic acid ameliorates vascular remodeling in pulmonary arterial hypertension via the downregulation of STAT3 signaling.
    J Pharmacol Sci. 2023;151:119-127.
    PubMed         Abstract available

    J Physiol

  30. JONES XM, Fox R, Motawakel J, Trivedi RK, et al
    Reversal of right ventricular pressure loading improves function independent of fibrosis.
    J Physiol. 2023;601:397-399.

    JACC Asia

  31. ZENG Y, Yu Q, Maimaitiaili N, Li B, et al
    Clinical and Predictive Value of Computed Tomography Angiography in High-Altitude Pulmonary Hypertension.
    JACC Asia. 2022;2:803-815.
    PubMed         Abstract available

  32. EJIRI K, Ogawa A, Shimokawahara H, Matsubara H, et al
    Treatment of Vascular Injury During Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    JACC Asia. 2022;2:831-842.
    PubMed         Abstract available

  33. CAO Y, Zhang Y, Song J
    Multi-Imaging Modality Facilitates Screening of Pulmonary Hypertension at High Altitude.
    JACC Asia. 2022;2:816-818.

    Life Sci

  34. MARUYAMA H, Sakai S, Dewachter L, Dewachter C, et al
    Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation.
    Life Sci. 2023;315:121372.
    PubMed         Abstract available

    Nat Med

    Merck bets on sotatercept in pulmonary arterial hypertension.
    Nat Med. 2023;29:2-3.

    Pediatr Cardiol

  36. SHOROFSKY MJ, Morgan GJ, Mejia E, Rodriguez SA, et al
    Management of Complex Pulmonary Vein Stenosis at Altitude Combining Comprehensive Percutaneous Interventional Treatment with Sirolimus, Pulmonary Hypertension Medications and Intraluminal Imaging with Optical Coherence Tomography.
    Pediatr Cardiol. 2023 Feb 1. doi: 10.1007/s00246-023-03102.
    PubMed         Abstract available

    Pediatr Int

  37. WADA MK, Fukuhara Y, Hayakawa I, Kaname T, et al
    KARS-related diseases with macrothrombocytes and pulmonary arterial hypertension.
    Pediatr Int. 2023;65:e15428.

    Pulm Circ

  38. GONZALES J, Fraidenburg DR
    Caught in a vicious cycle: Cell-free hemoglobin and the pathogenesis of pulmonary hypertension.
    Pulm Circ. 2023;13:e12194.


  39. UZUN S, Uzun F, Ercal O
    Optical coherence tomography angiography findings in patients with chronic thromboembolic pulmonary hypertension.
    Retina. 2022 Dec 26. doi: 10.1097/IAE.0000000000003716.

    Dr. Salih Uzun et al. Letter to the Editor: Comment on 'Optical coherence tomography angiography findings in patients with chronic thromboembolic pulmonary hypertension.
    Retina. 2022 Dec 26. doi: 10.1097/IAE.0000000000003717.

    Rev Esp Cardiol (Engl Ed)

  41. LUNA-LOPEZ R, de Pablo Gafas A, Escribano Subias P, Lopez Gude MJ, et al
    Double lung transplantation in pulmonary arterial hypertension associated with congenital heart disease.
    Rev Esp Cardiol (Engl Ed). 2023;76:132-134.

    Rev Mal Respir

  42. LE PAVEC J, Savale L, Prevot G, Montani D, et al
    [Lung transplantation for severe pulmonary hypertension].
    Rev Mal Respir. 2023 Jan 30:S0761-8425(22)00467.

    Sci Rep

  43. XANTHOULI P, Gordjani O, Benjamin N, Trudzinski FC, et al
    Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension.
    Sci Rep. 2023;13:1839.
    PubMed         Abstract available

    Yonsei Med J

  44. KIM HH, Lee HS, Kim HS, Youn YN, et al
    Clinical Outcomes of Endoscope-Assisted Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
    Yonsei Med J. 2023;64:104-110.
    PubMed         Abstract available

    Zhonghua Er Ke Za Zhi

  45. ZHAN TL, Chen YW, Wu JJ, Li F, et al
    [A case of severe pulmonary hypertension in children treated by transcatheter Potts shunt].
    Zhonghua Er Ke Za Zhi. 2023;61:169-171.

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.